<DOC>
	<DOC>NCT00106821</DOC>
	<brief_summary>The purpose of this study is to look at the benefits of tiotropium, an approved drug for the treatment of bronchospasm associated with COPD (chronic obstructive pulmonary disease), in a population of patients with COPD who are of African American descent.</brief_summary>
	<brief_title>Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Male or female of African descent 40 years of age or older Diagnosis of COPD History of smoking at least one pack per day for at least 10 years Currently experiencing shortness of breath at least with exertion Asthma Recent myocardial infarction or hospitalization for congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>